.Nature Medicine, Published online: 30 July 2024 doi:10.1038/ d41591-024-00054-wThe antitoxin-- medicine conjugate (ADC) tisotumab vedotin caused boosted progression-free and also total survival, triggering FDA approval as well as a brand new treatment choice for clients.